Cullinan Therapeutics (CGEM) Other Non Operating Income: 2020-2024
Historic Other Non Operating Income for Cullinan Therapeutics (CGEM) over the last 5 years, with Dec 2024 value amounting to -$199,000.
- Cullinan Therapeutics' Other Non Operating Income fell 139.26% to -$117,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $239,000, marking a year-over-year increase of 305.08%. This contributed to the annual value of -$199,000 for FY2024, which is 183.26% down from last year.
- Per Cullinan Therapeutics' latest filing, its Other Non Operating Income stood at -$199,000 for FY2024, which was down 183.26% from $239,000 recorded in FY2023.
- Cullinan Therapeutics' 5-year Other Non Operating Income high stood at $239,000 for FY2023, and its period low was -$199,000 during FY2024.
- In the last 3 years, Cullinan Therapeutics' Other Non Operating Income had a median value of $57,000 in 2022 and averaged $32,333.
- Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 812.50% in 2022, then crashed by 183.26% in 2024.
- Over the past 5 years, Cullinan Therapeutics' Other Non Operating Income (Yearly) stood at -$11,000 in 2020, then climbed by 27.27% to -$8,000 in 2021, then surged by 812.50% to $57,000 in 2022, then spiked by 319.30% to $239,000 in 2023, then plummeted by 183.26% to -$199,000 in 2024.